301188.SZ
力诺药包
SZSE · Consumer Cyclical · C 制造业 · CN
CNY 37.46
−3.95%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.0B | 981.5M | 1.1B | 947.4M | 822.0M |
| Cost of Revenue | 805.3M | 774.1M | 875.4M | 782.2M | 640.4M |
| Gross Profit | 220.3M | 207.3M | 205.5M | 165.2M | 181.6M |
| Operating Expenses | |||||
| R&D Expense | 34.4M | 34.4M | 33.8M | 30.1M | 26.0M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 57.3M | 52.4M | 38.5M | 28.2M | 24.8M |
| Selling & Marketing Expense | 62.1M | 61.7M | 48.5M | 39.5M | 25.5M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 185.8M | 180.0M | 145.2M | 109.1M | 73.7M |
| Cost and Expenses | 991.1M | 954.1M | 1.0B | 891.3M | 714.1M |
| Operating Income (EBIT) | 56.1M | 50.6M | 72.1M | 72.9M | 127.0M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 54.9M | 49.2M | 71.4M | 72.8M | 126.7M |
| Income Tax Expense | 14.7M | 9.6M | 5.4M | 6.9M | 10.1M |
| Bottom Line | |||||
| Net Income | 40.1M | 39.7M | 66.1M | 65.9M | 116.7M |
| Earnings from Cont. Ops | 40.1M | 39.7M | 66.1M | 65.9M | 116.7M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 40.1M | 39.7M | 66.1M | 65.9M | 116.7M |
| Per Share | |||||
| Basic EPS | CN¥0.17 | CN¥0.17 | CN¥0.29 | CN¥0.28 | CN¥0.50 |
| Diluted EPS | CN¥0.17 | CN¥0.17 | CN¥0.29 | CN¥0.30 | CN¥0.50 |
| Revenue Per Share | CN¥4.25 | CN¥4.21 | CN¥4.74 | CN¥4.02 | CN¥3.52 |
| Shares | |||||
| Basic Shares Outstanding | 241.2M | 233.3M | 227.8M | 235.4M | 233.3M |
| Diluted Shares Outstanding | 241.2M | 233.3M | 227.8M | 235.4M | 233.3M |
| Profitability Metrics | |||||
| EBITDA | — | 180.4M | 181.9M | 160.0M | 196.4M |
| D&A | — | 129.8M | 109.8M | 87.1M | 69.4M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026